蠟筆小新食品(01262.HK)預計中期由虧轉盈2000萬至3000萬元
格隆匯8月10日丨蠟筆小新食品(01262.HK)發佈公吿,公司預期截至2021年6月30日止六個月將錄得除税後溢利,金額約人民幣2,000萬元至人民幣3,000萬元,而2020年同期則為除税後虧損人民幣7,660萬元。
有關除税後溢利增加主要歸因於:(i)由於果凍產品的收益增加,毛利提升約人民幣3,540萬元;(ii)截至2021年6月30日止六個月出售物業所得收益約人民幣1,340萬元;及(iii)截至2021年6月30日止六個月並未撇銷經拆除物業(截至2020年6月30日止六個月:人民幣6,600萬元)。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.